COST NO FEENO SET ASIDE USED.

THE LELAND STANFORD JUNIOR UNIVERSITY - COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.

PIID: 75N93020C00054Solicitation ID: HHS-NIH-NIAID-BAA2020-1

Signed Date: Jan 7, 2026Effective Date: Sep 1, 2020End Date: Closes in 1357 days

Award $

$25.6M

Vendor

THE LELAND STANFORD JUNIOR UNIVERSITY

NAICS

541715

Signed Date

Jan 7, 2026

Key Details

Dollars Obligated

$25.6M

Base & All Options

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

Product Service Code

AJ12 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

STANFORD, CA, 943052004, CD-CA-16

Description

COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.

Context & Analysis

On Jan 7, 2026, Department of Health and Human Services obligated $25,640,419.95 to THE LELAND STANFORD JUNIOR UNIVERSITY for covid-19. to develop small synthetic chemical molecules as broadly active antiviral for the treatment of viral infections.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 23 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in STANFORD, CA. The contract is scheduled through May 31, 2030. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.